Overview of essential tremor
- PMID: 20856604
- PMCID: PMC2938289
- DOI: 10.2147/ndt.s4795
Overview of essential tremor
Abstract
Essential tremor (ET) is one of the most common movement disorders in the world. Despite this, only one medication (propranolol) is approved by the Food and Drug Administration (FDA) to treat it. Fortunately, recent studies have identified some additional medications as treatment of ET. Surgical procedures, such as deep brain stimulation of the ventral intermediate nucleus of the thalamus, offer treatment for refractory tremor. The epidemiology, pathogenesis, and medical and surgical treatment of ET will be discussed in this paper.
Keywords: Essential tremor; diagnosis; pathogenesis; treatment.
References
-
- Physicians’ Desk Reference. 63rd ed. Montvale, NJ: Thomson PDR; 2009.
-
- Benito-Leon J, Louis ED, Bermejo-Pareja F. Population-based case-control study of cognitive function in essential tremor. Neurology. 2001;66:69–74. - PubMed
-
- Louis ED, Benito-Leon J, Bermejo-Pareja F. Self-reported depression and anti-depressant medication use in essential tremor: cross-sectional and prospective analyses in a population-based study. Eur J Neurol. 2007;14:1138–1146. - PubMed
-
- Louis ED, Ottman R, Hauser WA. How common is the most common adult movement disorder? estimates of the prevalence of essential tremor throughout the world. Mov Disord. 1998;13(1):5–10. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
